6533b7d9fe1ef96bd126c081
RESEARCH PRODUCT
Reveglucosidase alfa (BMN 701), a GILT-tagged recombinant human acid alpha glucosidase (rhGAA), evaluation in late-onset Pompe disease: Preliminary clinical efficacy and safety results of an extension study (72-week results)
C. HeusnerW. DummerClaude DesnuelleRichard J. BarohnEugen MengelDrago BratkovicPascal LaforêtDerralynn HughesKe YangBarry J. ByrneMark RobertsTarekegn Hiwotsubject
Neurologybusiness.industryExtension studyPediatrics Perinatology and Child HealthMedicineRecombinant human acid alpha-glucosidaseLate onsetNeurology (clinical)DiseaseClinical efficacybusinessVirologyGenetics (clinical)year | journal | country | edition | language |
---|---|---|---|---|
2015-10-01 | Neuromuscular Disorders |